Author:
Au Wing Y.,Caguioa Priscilla B.,Chuah Charles,Hsu Szu Chun,Jootar Saengsuree,Kim Dong-Wook,Kweon Il-Young,O’Neil William M.,Saikia Tapan K.,Wang Jianxiang
Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. North American Association of Central Cancer Registries (2007) North American age-specific invasive cancer incidence rates, chronic myeloid leukemia, 2000–2004. http://www.cancer-rates.info/naaccr/.
2. Laneuville P, Barnett MJ, Belanger R, et al. Recommendations of the Canadian consensus group on the management of chronic myeloid leukemia. Curr Oncol. 2006;13(6):201–21.
3. Baccarani M, Saglio G, Goldman J, et al. Evolving concepts in the management of chronic myeloid leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet. Blood. 2006;108(6):1809–20.
4. National Comprehensive Cancer Network. Chronic myelogenous leukemia. Version 2. Fort Washington: National Comprehensive Cancer Network; 2007.
5. Arora B, Kumar L, Kumaru M, Sharma A, Wadhwa J, Kochupillai V. Therapy with imatinib for chronic myeloid leukaemia. Ind J Med Paediatr Oncol. 2005;26:5–18.
Cited by
84 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献